. Review.
.
. Schoenfeld AJ, et al. Ann Oncol. 2021 Sep 3:S0923-7534(21)04455-0. doi: 10.1016/j.annonc.2021.08.2151. Online ahead of print. Ann Oncol. 2021. PMID: 34487855
.
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
.
Item in Clipboard
Item in Clipboard